[Psychotropic drugs and pregnancy: a review (author's transl)].
A wide range of literature on the use of psychoactive drugs in pregnancy and breastfeeding is reviewed critically and systemically. The question of 'guidelines' for an adequate treatment of pregnant psychiatric patients cannot be answered in an unequivocal or reassuring way. First of all, it is our inconclusive knowledge of this subject which demands caution prior to prescribing. Only in second line, isolated evidence of possible but mostly unproven damage to unborn children by the use of individual psychotropic drugs should be taken into account.
D000014:Abnormalities, Drug-Induced / Q000209:etiology; D000928:Antidepressive Agents / Q000627:therapeutic use; D014150:Antipsychotic Agents / Q000627:therapeutic use; D002675:Child, Preschool; D002869:Chromosome Aberrations; D005260:Female; D006801:Humans; D007223:Infant; D007231:Infant, Newborn; D008094:Lithium / Q000627:therapeutic use; D008431:Maternal-Fetal Exchange / Q000187:drug effects; D011247:Pregnancy; D011248:Pregnancy Complications / Q000188:drug therapy*; D011619:Psychotropic Drugs / Q000009:adverse effects / Q000627:therapeutic use*; D012559:Schizophrenia / Q000188:drug therapy; D014149:Tranquilizing Agents / Q000627:therapeutic use
D000928:Antidepressive Agents; D014150:Antipsychotic Agents; D011619:Psychotropic Drugs; D014149:Tranquilizing Agents; D008094:Lithium
Psychopharmaka und Schwangerschaft: Eine Ubersicht.